Novavax Inc (NVAX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,753,373,000
EV to revenue ratio (TTM)
3.186
EV to ebitda
1.718
Financial Performance
Revenue (TTM)
413,796,000
Gross profit (TTM)
-10,583,000
EBITDA
-101,552,000
Profitability
Operating margin (TTM)
-89.60%
Profit margin
-59.90%
Return on assets (TTM)
-6.51%
Return on equity (TTM)
-898.00%
Per Share Metrics
Revenue per share (TTM)
2.54
EPS
-1.53
Diluted EPS (TTM)
-1.53
Book value
-1.16
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
2.585
PEG ratio
1.322
Price to sales ratio (TTM)
4.237
Price to book ratio (TTM)
41.23
Growth
Quarterly earnings growth (YoY)
-76.30%
Quarterly revenue growth (YoY)
-38.10%
Analyst Sentiment
Strong buy
0
Buy
5
Hold
1
Sell
1
Strong sell
2
Risk & Volatility
Beta
2.45